Disparities in Absolute Denial of Modern Hepatitis C Therapy&#160;by&#160;Type of Insurance (Q37018340)

17 August 2017

Disparities in Absolute Denial of Modern Hepatitis C Therapy by Type of Insurance (English)

1 reference

17 August 2017

1 reference

13

K Rajender Reddy

1 reference

17 August 2017

12

Peter P Reese

1 reference

17 August 2017

11

Jalpa A Doshi

1 reference

17 August 2017

Vincent Lo Re

1

1 reference

17 August 2017

Charitha Gowda

2

1 reference

17 August 2017

Paul N Urick

3

1 reference

17 August 2017

Joshua T Halladay

4

1 reference

17 August 2017

Amanda Binkley

5

1 reference

17 August 2017

Dena M Carbonari

6

1 reference

17 August 2017

Kathryn Battista

7

1 reference

17 August 2017

Cassandra Peleckis

8

1 reference

17 August 2017

Jody Gilmore

9

1 reference

17 August 2017

Jason A Roy

10

1 reference

17 August 2017

Jay R Kostman

14

1 reference

17 August 2017

language of work or name

English

0 references

publication date

5 April 2016

1 reference

Clinical Gastroenterology and Hepatology

17 August 2017

1 reference

17 August 2017

14

1 reference

17 August 2017

7

1 reference

17 August 2017

1035-1043

1 reference

Missing Data: How to Best Account for What Is Not Known

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Access to Costly New Hepatitis C Drugs: Medicine, Money, and Advocacy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1: Summary of California Technology Assessment Forum Report

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

The Affordable Care Act at 5 Years

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Cost-effectiveness of novel regimens for the treatment of hepatitis C virus

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Natural history of hepatitis C

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Global distribution and prevalence of hepatitis C virus genotypes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

A modified poisson regression approach to prospective studies with binary data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Descriptive analyses of the integrity of a US Medicaid claims database

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Limited Access to New Hepatitis C Virus Treatment Under State Medicaid Programs

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

The impact of specialty pharmaceuticals as drivers of health care costs

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

When can odds ratios mislead?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Medicare at 50--moving forward.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Quantum leaps, microeconomics, and the treatment of patients with hepatitis C and HIV coinfection

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

The high price of the new hepatitis C virus drugs

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

HCV infection and the incidence of CKD.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

New Expensive Treatments for Hepatitis C Infection

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4912853

Early Patterns of Sofosbuvir Utilization by State Medicaid Programs

4 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27062903

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tackling the hepatitis C cost problem: A test case for tomorrow's cures

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27062903

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A case study on the use of multiple imputation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27062903

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CGH.2016.03.040

1 reference

17 August 2017

1 reference

17 August 2017

1 reference